Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Troy ME"'
Autor:
Troy Messick
Publikováno v:
Glossa, Vol 8, Iss 1 (2023)
This paper presents a novel case study of a 3/4 agreement pattern typically found with hybrid nouns. This case study involves agreement and binding with Quantified NPs in English. I propose an analysis that relies on different classes of agreement ta
Externí odkaz:
https://doaj.org/article/03887963a6ac4898b15580b25ec44caa
Publikováno v:
Religions, Vol 15, Iss 3, p 365 (2024)
Islam was an important factor in the decolonisation of Muslim countries from European colonial rule during the 19th and 20th centuries. However, Muslims are among the migrant-settler populations of Australia, Canada, the United States, and other Brit
Externí odkaz:
https://doaj.org/article/0020cfb56f094df3a8f7ac3dfa3cf41c
Autor:
Mitu C. Acharjee, Brad Ledden, Brian Thomas, Xianglan He, Troy Messina, Jason Giurleo, David Talaga, Jiali Li
Publikováno v:
Sensors, Vol 24, Iss 1, p 81 (2023)
Protein aggregation is linked to many chronic and devastating neurodegenerative human diseases and is strongly associated with aging. This work demonstrates that protein aggregation and oligomerization can be evaluated by a solid-state nanopore metho
Externí odkaz:
https://doaj.org/article/244691a9697b42c3abc551c1a24af58b
Autor:
Rebecca Brandon, Yannan Jiang, Rui Qian Yeu, Ry Tweedie-Cullen, Kate Smallman, Glenn Doherty, Kerry A. Macaskill-Smith, Rebekah J. Doran, Penny Clark, Allan Moffitt, Troy Merry, Norma Nehren, Frances King, Jennie Harré Hindmarsh, Megan Patricia Leask, Tony R. Merriman, Brandon Orr-Walker, Peter R. Shepherd, Ryan Paul, Rinki Murphy
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2023)
BackgroundUnderstanding which group of patients with type 2 diabetes will have the most glucose lowering response to certain medications (which target different aspects of glucose metabolism) is the first step in precision medicine.AimsWe hypothesize
Externí odkaz:
https://doaj.org/article/cffdbcc133504c5d9b4a6129c12786b9
Autor:
Troy Messick
Publikováno v:
Glossa, Vol 5, Iss 1 (2020)
This squib argues that matrix subject wh-phrases reside in SpecCP and moreover during the course of the derivation, never move to SpecTP. This observation raises an immediate problem for languages with a strong EPP requirement on T, such as English.
Externí odkaz:
https://doaj.org/article/a75797b92cb943fa8e8680f7b76d2331
Autor:
Timothy Hoggard, Ivan Liachko, Cassaundra Burt, Troy Meikle, Katherine Jiang, Gheorghe Craciun, Maitreya J. Dunham, Catherine A. Fox
Publikováno v:
G3: Genes, Genomes, Genetics, Vol 6, Iss 4, Pp 993-1012 (2016)
The ability of plasmids to propagate in Saccharomyces cerevisiae has been instrumental in defining eukaryotic chromosomal control elements. Stable propagation demands both plasmid replication, which requires a chromosomal replication origin (i.e., an
Externí odkaz:
https://doaj.org/article/cb3bd1dbcd2b4d0c855051d7676cd891
Publikováno v:
Molecular Systems Biology, Vol 11, Iss 1, Pp 1-16 (2015)
Abstract Collective behavior in cellular populations is coordinated by biochemical signaling networks within individual cells. Connecting the dynamics of these intracellular networks to the population phenomena they control poses a considerable chall
Externí odkaz:
https://doaj.org/article/f0c0a079114b426690e00b49e5df02c4
Autor:
Pearsall RS; Acceleron Pharma, Cambridge, MA, USA. spearsall@xlrn.com., Davies MV; Acceleron Pharma, Cambridge, MA, USA., Cannell M; Acceleron Pharma, Cambridge, MA, USA., Li J; Acceleron Pharma, Cambridge, MA, USA., Widrick J; Division of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Mulivor AW; Acceleron Pharma, Cambridge, MA, USA.; The Hospital for Sick Children, Toronto, Ontario, Canada., Wallner S; Acceleron Pharma, Cambridge, MA, USA.; NovaRock Biotherapeutics, Princeton, NJ, USA., Troy ME; Acceleron Pharma, Cambridge, MA, USA., Spaits M; Acceleron Pharma, Cambridge, MA, USA., Liharska K; Acceleron Pharma, Cambridge, MA, USA.; Dragonfly Therapeutics, Waltham, MA, USA., Sako D; Acceleron Pharma, Cambridge, MA, USA., Castonguay R; Acceleron Pharma, Cambridge, MA, USA., Keates S; Acceleron Pharma, Cambridge, MA, USA., Grinberg AV; Acceleron Pharma, Cambridge, MA, USA.; Dragonfly Therapeutics, Waltham, MA, USA., Suragani RNVS; Acceleron Pharma, Cambridge, MA, USA., Kumar R; Acceleron Pharma, Cambridge, MA, USA.
Publikováno v:
Scientific reports [Sci Rep] 2019 Aug 06; Vol. 9 (1), pp. 11392. Date of Electronic Publication: 2019 Aug 06.
Autor:
Castonguay R; Acceleron Pharma, Cambridge, Massachusetts rcastonguay@acceleronpharma.com., Lachey J; Acceleron Pharma, Cambridge, Massachusetts., Wallner S; Acceleron Pharma, Cambridge, Massachusetts., Strand J; Acceleron Pharma, Cambridge, Massachusetts., Liharska K; Acceleron Pharma, Cambridge, Massachusetts., Watanabe AE; Acceleron Pharma, Cambridge, Massachusetts., Cannell M; Acceleron Pharma, Cambridge, Massachusetts., Davies MV; Acceleron Pharma, Cambridge, Massachusetts., Sako D; Acceleron Pharma, Cambridge, Massachusetts., Troy ME; Acceleron Pharma, Cambridge, Massachusetts., Krishnan L; Acceleron Pharma, Cambridge, Massachusetts., Mulivor AW; Acceleron Pharma, Cambridge, Massachusetts., Li H; Acceleron Pharma, Cambridge, Massachusetts., Keates S; Acceleron Pharma, Cambridge, Massachusetts., Alexander MJ; Acceleron Pharma, Cambridge, Massachusetts., Pearsall RS; Acceleron Pharma, Cambridge, Massachusetts., Kumar R; Acceleron Pharma, Cambridge, Massachusetts.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2019 Mar; Vol. 368 (3), pp. 435-445. Date of Electronic Publication: 2018 Dec 18.